Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Diabetes in pregnancy: how does it affect Kids' brains?

NCT ID NCT05754567

Knowledge-focused Sponsor: University of Manitoba Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 225 children whose mothers had type 1 diabetes during pregnancy and took part in the CONCEPTT trial. Researchers will assess the children's thinking, behavior, and emotional skills using parent questionnaires. The goal is to understand if maternal diabetes affects long-term brain development.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could reveal how maternal type 1 diabetes affects children's brain development, guiding future care and monitoring.
What could go wrong
This is an observational follow-up, not a treatment trial. It may find no clear links or be limited by the number of participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 225 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2023

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Children, ages 6 and up, of women with T1D who participated in the CONCEPTT trial

Ages

6 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children of women who participated in the CONCEPTT trial at selected recruiting sites Exclusion Criteria: * NA

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neurocognitive disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cognitive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neurocognitive disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    10 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Alberta Health Services

    RECRUITING

    Calgary, Alberta, T2T 5C7, Canada

  • Glasgow Royal Infirmary

    RECRUITING

    Glasgow, PA2 7DE, United Kingdom

  • Hospital de la Santa Creu

    RECRUITING

    Barcelona, Spain

  • IWK Health

    RECRUITING

    Halifax, Nova Scotia, B3K 6R8, Canada

  • Ipswich Hospital NHS Trust

    RECRUITING

    Ipswich, IP4 5PD, United Kingdom

  • Mt Sinai Hospital

    NOT_YET_RECRUITING

    Toronto, Ontario, M5T 3L9, Canada

  • NHS Lothian Royal Infirmary of Edinburgh

    RECRUITING

    Edinburgh, Scotland, EH16 4UX, United Kingdom

  • Southampton General Hospital

    RECRUITING

    Southampton, SO16 6YD, United Kingdom

  • St. James's Hospital, Leeds Teaching Hospitals Trust NHS Trust

    RECRUITING

    Leeds, LS9 7TF, United Kingdom

  • The Ottawa Hospital - Riverside Campus

    RECRUITING

    Ottawa, Ontario, K1H 7W9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.